E2	Condition:T2 Name:T51
E3	Observation:T3 Name:T52 Numeric-Filter:E4
E4	Eq-Comparison:T4 Value:T53 Operator:T54 Value2:T55
E5	Observation:T5 Name:T56 Stability:T57
E6	Negation:T6 Negates:E7 Negates2:E26
E7	Condition:T7 Name:T58
E9	Condition:T9 Name:T59
E10	Condition:T10 Name:T60
E12	Eq-Comparison:T12 Operator:T62 Value:T63 Unit:T64 Per:T65
E13	Procedure:T13 Name:T67
E14	Modifier:T14 Modifies:E15
E15	Drug:T15 
E16	Assertion:T16 Asserted:T68
E17	Observation:T17 Name:T69 Stability:T68
E18	Drug:T18 Name:T98 Dose:T70 Dose2:E19
E19	Eq-Comparison:T19 Operator:T71 Value:T72 Unit:T73 Per:T74
E20	Drug:T20 Name:T75
E21	Eq-Comparison:T21 Value:T76 Temporal-Unit:T77
E25	Drug:T25 Name:T79
E27	Drug:T27 Name:T81
E28	Drug:T28 Name:T82
E29	Drug:T29 Name:T102
E30	Drug:T30 Name:T84
E32	Drug:T32 Name:T85
E34	Drug:T34 Name:T86
E35	Allergy:T35 Name:E30 Name2:E32 Name3:E34
E36	Eq-Comparison:T36 Value:T87 Unit:T88
E37	Observation:T37 Name:T89 Numeric-Filter:E36
E38	Observation:T38 Name:T90 Numeric-Filter:E36
E39	Observation:T39 Name:T91 Numeric-Filter:E36
E40	Observation:T40 Name:T92
E41	Observation:T41 Name:T93 Numeric-Filter:E36
E42	Observation:T42 Name:T94
E43	Exception:T43 From:E42 Except:E44 Except2:E45
E44	Condition:T44 Name:T95
E45	Observation:T45 Name:T96
E46	Exception:T46 From:E45 Except:E47
E47	Condition:T47 Name:T97
E26	Condition:T26 Name:T80
E48	Observation:T83 Numeric-Filter:E12 Name:T11
E49	Modifier:T66 Modifies:T67
E22	Drug:T22 Name:T23
E23	Provider:T24 
E24	Observation:T99 Name:T100 Provider:E23
E50	Modifier:T101 Modifies:T102
T2	Condition 46 59	premenopausal
T3	Observation 66 69	BMI
T4	Eq-Comparison 70 75	29-37
T5	Observation 81 87	Weight
T6	Negation 100 103	Not
T7	Condition 104 112	pregnant
T9	Condition 146 168	Ischemic heart disease
T10	Condition 174 206	Atherosclerotic valvular disease
T12	Eq-Comparison 221 244	>20 cigarettes per week
T13	Procedure 261 273	oophorectomy
T14	Modifier 279 290	Concomitant
T15	Drug 298 309	medications
T16	Assertion 315 318	can
T17	Observation 325 344	serum lipid profile
T18	Drug 366 374	fish oil
T19	Eq-Comparison 376 387	>3g per day
T20	Drug 400 407	STATINS
T21	Eq-Comparison 416 432	hold for 6 weeks
T25	Drug 472 478	Niacin
T27	Drug 508 526	thiazolidinediones
T28	Drug 537 550	Beta-blockers
T29	Drug 570 584	antipsychotics
T30	Drug 590 599	Lidocaine
T32	Drug 603 609	Niacin
T34	Drug 610 617	Niaspan
T35	Allergy 618 625	allergy
T36	Eq-Comparison 645 676	1.5 times upper limit of normal
T37	Observation 680 696	serum creatinine
T38	Observation 698 718	Alkaline phosphatase
T39	Observation 720 746	Aspartate aminotransferase
T40	Observation 748 751	AST
T41	Observation 754 778	Alanine aminotransferase
T42	Observation 780 783	ALT
T43	Exception 785 791	unless
T44	Condition 808 827	fatty liver disease
T45	Observation 829 844	Total bilirubin
T46	Exception 846 852	unless
T47	Condition 880 898	Gilbert's syndrome
T48	Life-Stage-And-Gender 25 30	Women
T49	Life-Stage-And-Gender 35 38	Men
T50	Life-Stage-And-Gender 40 45	Women
T51	Condition-Name 46 59	premenopausal
T52	Observation-Name 66 69	BMI
T53	Eq-Value 70 72	29
T54	Eq-Operator 72 73	-
T55	Eq-Value 73 75	37
T56	Observation-Name 81 87	Weight
T57	Stability 88 94	stable
T58	Condition-Name 104 112	pregnant
T59	Condition-Name 146 168	Ischemic heart disease
T60	Condition-Name 174 206	Atherosclerotic valvular disease
T62	Eq-Operator 221 222	>
T63	Eq-Value 222 224	20
T64	Eq-Unit 225 235	cigarettes
T65	Eq-Temporal-Unit 240 244	week
T67	Procedure-Name 261 273	oophorectomy
T68	Stability 319 324	alter
T69	Observation-Name 325 344	serum lipid profile
T70	Polarity 356 360	High
T71	Eq-Operator 376 377	>
T72	Eq-Value 377 378	3
T73	Eq-Unit 378 379	g
T74	Eq-Temporal-Unit 384 387	day
T75	Drug-Name 400 407	STATINS
T76	Eq-Value 425 426	6
T77	Eq-Temporal-Unit 427 432	weeks
T79	Drug-Name 472 478	Niacin
T81	Drug-Name 508 526	thiazolidinediones
T82	Drug-Name 537 550	Beta-blockers
T84	Drug-Name 590 599	Lidocaine
T85	Drug-Name 603 609	Niacin
T86	Drug-Name 610 617	Niaspan
T87	Eq-Value 645 648	1.5
T88	Eq-Unit 655 676	upper limit of normal
T89	Observation-Name 680 696	serum creatinine
T90	Observation-Name 698 718	Alkaline phosphatase
T91	Observation-Name 720 746	Aspartate aminotransferase
T92	Observation-Name 748 751	AST
T93	Observation-Name 754 778	Alanine aminotransferase
T94	Observation-Name 780 783	ALT
T95	Condition-Name 808 827	fatty liver disease
T96	Observation-Name 829 844	Total bilirubin
T97	Condition-Name 880 898	Gilbert's syndrome
T26	Condition 113 120	nursing
T80	Condition-Name 113 120	nursing
T83	Observation 212 219	Smokers
T66	Modifier 251 260	Bilateral
T98	Drug-Name 366 374	fish oil
T22	Drug 489 497	Fibrates
T23	Drug-Name 489 497	Fibrates
T24	Provider 445 448	PCP
T99	Observation 451 459	approval
T100	Observation-Name 451 459	approval
T101	Modifier 561 569	Atypical
T102	Drug-Name 570 584	antipsychotics
T11	Observation-Name 212 219	Smokers
A1	Assertion-Type-Value E16 hypothetical
A2	Life-Stage-And-Gender-Type T48 female
A3	Life-Stage-And-Gender-Type T49 male
A4	Life-Stage-And-Gender-Type T50 female
A5	Observation-Type-Value E3 vital
A6	Eq-Operator-Value T54 BETWEEN
A7	Observation-Type-Value E5 vital
A8	Stability-Value T57 stable
A9	Eq-Operator-Value T62 GT
A10	Eq-Temporal-Unit-Value T65 week
A12	Stability-Value T68 change
A13	Observation-Type-Value E17 lab
A14	Polarity-Value T70 high
A15	Eq-Operator-Value T71 GT
A16	Eq-Temporal-Unit-Value T74 day
A17	Eq-Temporal-Unit-Value T77 week
A18	Eq-Unit-Value T88 ref-range-normal
A19	Observation-Type-Value E37 lab
A20	Observation-Type-Value E38 lab
A21	Observation-Type-Value E39 lab
A22	Observation-Type-Value E40 lab
A23	Observation-Type-Value E41 lab
A24	Observation-Type-Value E42 lab
A25	Observation-Type-Value E45 lab
A11	Observation-Type-Value E48 social-habit
R1	If-Then Arg1:T50 Arg2:E2
R2	Caused-By Arg1:T68 Arg2:E15
R3	Equivalent-To Arg1:E19 Arg2:T70
R4	Abbrev-Of Arg1:E40 Arg2:E39
R5	Abbrev-Of Arg1:E42 Arg2:E41
R6	Or Arg1:T48 Arg2:T49
R7	Or Arg1:E7 Arg2:E26
R8	Or Arg1:E30 Arg2:E32
R9	Or Arg1:E32 Arg2:E34
R10	Or Arg1:E37 Arg2:E38
R11	Or Arg1:E38 Arg2:E39
R12	Or Arg1:E44 Arg2:E45
